February 1, 2009Journal of Clinical HypertensionOpen Access

Hyperkalemia as a Constraint to Therapy With Combination Renin‐Angiotensin System Blockade: The Elephant in the Room

View Full Paper

Ask AI

Bookmark

Why the study?

Does dual RAAS blockade increase the risk of hyperkalemia in patients with cardiovascular and renal disease?

Population

Patients with cardiovascular disease and chronic kidney disease

Design

Review

Authors

MEMurray EpsteinUniversity of Miami

Discussion

Member takes

Implication

Prudent hyperkalemia monitoring advised with dual RAAS blockade in HF and post-MI; leaves open standardized reporting and risk quantification in future studies.

Structured PICO

Does dual RAAS blockade increase the risk of hyperkalemia in patients with cardiovascular and renal disease?

Population

Patients with cardiovascular disease (including heart failure and post-myocardial infarction) and chronic kidney disease

Intervention

Dual renin-angiotensin-aldosterone system (RAAS) blockade (combination of an ACE inhibitor or ARB with an aldosterone receptor antagonist)

Outcome

Hyperkalemiasafety

While dual RAAS blockade offers cardiovascular and renal benefits, it significantly increases the risk of hyperkalemia, necessitating careful monitoring and standardized reporting.

Limitations

Reporting of hyperkalemia has been haphazard, inconsistent, and often confounded by concomitant interventions
Lack of consensus on the definition of mild, moderate, or severe hyperkalemia
Population-based studies lack direct measures of potassium, creatinine, and medication adherence

Cite This Study

Murray Epstein (2009) studied this question.

synapsesocial.com/papers/6a8861348dfe8b7ec5a54587 https://doi.org/10.1111/j.1751-7176.2008.00071.x

View Full Paper

Ask AI

Bookmark

Implication

Prudent hyperkalemia monitoring advised with dual RAAS blockade in HF and post-MI; leaves open standardized reporting and risk quantification in future studies.

Hyperkalemia as a Constraint to Therapy With Combination Renin‐Angiotensin System Blockade: The Elephant in the Room

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Hyperkalemia as a Constraint to Therapy With Combination Renin‐Angiotensin System Blockade: The Elephant in the Room

Discussion

Member takes

Implication

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider